Hydroxychloroquine Market (By Type: 200mg, 100mg, Other; By Sales Channel: COVID-19, Rheumatoid Arthritis, Lupus Erythematosus, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global hydroxychloroquine market size is expected to reach around US$ 6 Bn by 2027 and growing at a CAGR of 32% during the forecast period 2020 to 2027.

Hydroxychloroquine is used by people suffering such debilitating health complications as a miracle drug used to diagnose and control a variety of diseases such as rheumatoid arthritis and autoimmune disease known as lupus. The antimalarial now experiences a increasing demand from certain countries as they guide effort into managing the human and humanitarian pandemic COVID-19. There are research tests in progress that can help to determine medication market for the prevention and treatment of lethal viral infections.

The report provides analysis of global Hydroxychloroquine market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2019 is considered as the base year.

Dynamics

Hydroxychloroquine industry has strong demands in healthcare environment despite of a variety of reasons. The link between COVID-19 diagnosis and safety-is a key catalyst today-approvals of COVID will also be sought from the FDA.

India, a major hydroxychloroquine manufacturer and exporter, is growing production to meet the demand for more than 9 metric tons of API, the active pharmaceutical ingredient, coming from a variety of countries like the United States of America to which it is dischargeing over 3 million tablets. It must be noted that Intas Pharmaceuticals, Macleods Pharmaceuticals, McW Healthcare of Indore, and Cipla are some of the leading Indian manufacturers on the market.

Positive cases of coronavirus reached to more the one million threshold and 100,000 people died of this deadly disease. It has impacts on life and livelihoods, and it drives the governments to take steps that are proportionate and sometimes dramatic. Nevertheless, the rise in rheumatoid arthritis and lupus occurrence will also drive the industry over the projected period.

Notable Development

The very important and efficient hydroxychloroquine medication in recent times has become increasingly common, thanks to results from a French study which shows that they are successful in treating the planet's diseases by Coronavirus. However, the analysis is completed with a snap by peer examination and by those in the physician field. The following are some of the important changes of the modern past.

Regional Overview

Asia Pacific dominates the global hydroxychloroquine market in 2019 led by India. North American region is anticipated to rise at a significant CAGR amid the forecast period due to the factors such as the growing number of Lupus patients. Moreover, through regulatory licenses, the United States leads tremendously to business growth; a large deal of clinical trials takes place.

Report coverage

The market research study on “Hydroxychloroquine Market (Hydroxychloroquine Market By Type: 200mg, 100mg, Other; Hydroxychloroquine Market By Application: COVID-19, Rheumatoid Arthritis, Lupus Erythematosus, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers a detailed insights on the global Hydroxychloroquine market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report covers global Hydroxychloroquine market size, and segment markets by type, sales channel, end use, and geography along with the information on companies operating in the market. The Hydroxychloroquine market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.  

The global Hydroxychloroquine market is segmented as below:

Market Segmentation

Hydroxychloroquine Market By Type

  • 200mg
  • 100mg
  • Other

Hydroxychloroquine Market By Sales Channel

  • COVID-19
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Others

Hydroxychloroquine Market By Geography

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Mexico
  • Brazil
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of MEA

Key Players and Market Situation

Participants include major global players such Novartis, Actavis (TEVA ), Apotex Corporation, Sanofi, Hikma Pharmaceuticals, Mylan, Covis Pharmaceutical, Aphena Pharma, Concordia Healthcare, Cardinal Health, Cinkate Corporation, Zydus Cadila, Others.

The firms concentrate primarily on technological growth, acquisition and acquisitions as well as global development to achieve a large market share. Given that the prescription substance is viewed as a possible treatment for COVID-19, the production of the hydrochloroquine medication has risen in significant numbers.


Frequently Asked Questions

Hydroxychloroquine is used by people suffering such debilitating health complications as a miracle drug used to diagnose and control a variety of diseases such as rheumatoid arthritis and autoimmune disease known as lupus.

The antimalarial now experiences a increasing demand from certain countries as they guide effort into managing the human and humanitarian pandemic COVID-19.

Acumen Research and Consulting, the global hydroxychloroquine market size is projected to reach around US$ 6 Bn by 2027.

The global hydroxychloroquine market is growing at a CAGR of 32% during the forecast period 2020 to 2027.

Asia Pacific dominates the global hydroxychloroquine market in 2019 led by India.

North American region is anticipated to rise at a significant CAGR amid the forecast period due to the factors such as the growing number of Lupus patients. Moreover, through regulatory licenses, the United States leads tremendously to business growth; a large deal of clinical trials takes place.

Participants include major global players such Novartis, Actavis (TEVA ), Apotex Corporation, Sanofi, Hikma Pharmaceuticals, Mylan, Covis Pharmaceutical, Aphena Pharma, Concordia Healthcare, Cardinal Health, Cinkate Corporation, Zydus Cadila, Others.

Cart Summary


60